Literature DB >> 16474623

Therapy Insight: bladder dysfunction associated with multiple sclerosis.

Vinay Kalsi1, Clare J Fowler.   

Abstract

Bladder dysfunction is a common problem for patients with multiple sclerosis. The severity of symptoms often correlate with the degree of spinal cord involvement and, hence, the patient's general level of disability. The emphasis of management is now mainly medical and is increasingly offered by nonurologists. Treatments can be highly effective, relieving patients of what are otherwise very troublesome symptoms that would compound their neurological disability. This article gives an overview of the neural control of the bladder, followed by an explanation of the pathophysiology of detrusor overactivity secondary to neurological disease. A review of methods available for treating bladder dysfunction in multiple sclerosis then follows. The treatment options for this disorder are largely medical and include established first-line measures such as anticholinergics, clean intermittent self-catheterization and the use of desmopressin, as well as potential second-line agents, such as cannabinoids, intravesical vanilloids and intradetrusor botulinum neurotoxin type A. The diminishing role of surgical intervention is also discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16474623     DOI: 10.1038/ncpuro0323

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  23 in total

Review 1.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

2.  Caregiver burden among informal caregivers assisting people with multiple sclerosis.

Authors:  Robert J Buchanan; Dagmar Radin; Chunfeng Huang
Journal:  Int J MS Care       Date:  2011

Review 3.  The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

Authors:  A Tubaro; F Puccini; C De Nunzio; G A Digesu; S Elneil; C Gobbi; V Khullar
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

4.  Associations Between Bladder Dysfunction and Falls in People with Relapsing-Remitting Multiple Sclerosis.

Authors:  Jaime E Zelaya; Charles Murchison; Michelle Cameron
Journal:  Int J MS Care       Date:  2017 Jul-Aug

Review 5.  Urothelial signaling.

Authors:  Lori A Birder
Journal:  Auton Neurosci       Date:  2009-08-08       Impact factor: 3.145

6.  Functional role of cannabinoid receptors in urinary bladder.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Michael Chancellor
Journal:  Indian J Urol       Date:  2010 Jan-Mar

7.  Simvastatin protects bladder and renal functions following spinal cord injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Peter C Te Chou; Ramanpreet K Dhindsa; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Mehmet Bilgen; John K Orak; Inderjit Singh
Journal:  J Inflamm (Lond)       Date:  2010-04-19       Impact factor: 4.981

Review 8.  Neurotrophins as regulators of urinary bladder function.

Authors:  Peter Ochodnicky; Célia D Cruz; Naoki Yoshimura; Francisco Cruz
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

9.  Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Guiming Liu; Adebola Fabiyi; Michael Kavran; Justin M Johnson; M Fatih Gulen; Ritika Jaini; Xiaoxia Li; Tara L Frenkl; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 10.  TRPs in bladder diseases.

Authors:  Lori A Birder
Journal:  Biochim Biophys Acta       Date:  2007-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.